Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
The FDA has deep concerns about its safety and efficacy
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, developed by Eli Lilly
Seeking Advice from a UK Healthcare Professional Anyone experiencing hair loss should consult their GP first to establish the underlying cause before using unregulated products
Features Benefits: How to use: Major Ingredients Petrolatum, Hydrogenated Polyisobutene, Polyisobutene, Phytosteryl/Isostearyl/Cetyl/Stearyl/Behenyl Dimer Dilinoleate, Butyrospermum Parkii (Shea) Butter, Diisostearyl Malate, Ethylene/Propylene/Styrene Copolymer, Sorbitan Sesquioleate, Microcrystalline Wax, Vanillyl Butyl Ether ,Butylene/Ethylene/Styrene Copolymer, Ethylhexylglycerin, Water, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Butylene Glycol, Melia Azadirachta Leaf Extract, Melia Azadirachta Flower Extract, Coccinia Indica Fruit Extract, Amber Powder, Mentha Piperita (Peppermint) Leaf Extract, Solanum Melongena (Eggplant) Fruit Extract, Ocimum Sanctum Leaf Extract, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Moringa Oleifera Seed Oil, Magnesium Ascorbyl Phosphate, Citric Acid, Betaine Salicylate, Anemarrhena Asphodeloides Root Extract Ingredients subject to change at manufacturer's discretion
.jpg)